ACAT1 and neoplasm: Our research demonstrated that TRIM59 facilitates ACAT1 ubiquitination in pRCC, thereby reducing endocytic phospholipid synthesis and inhibiting mitochondria-dependent apoptosis, ultimately promoting tumor growth (Fig. 7H).